These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 23388171)
1. Abnormal platelet amyloid-β protein precursor (AβPP) metabolism in Alzheimer's disease: identification and characterization of a new AβPP isoform as potential biomarker. Jelic V; Hagman G; Yamamoto NG; Teranishi Y; Nishimura T; Winblad B; Pavlov PF J Alzheimers Dis; 2013; 35(2):285-95. PubMed ID: 23388171 [TBL] [Abstract][Full Text] [Related]
2. Protein Expression of BACE1 is Downregulated by Donepezil in Alzheimer's Disease Platelets. Sarno TA; Talib LL; Joaquim HP; Bram JM; Gattaz WF; Forlenza OV J Alzheimers Dis; 2017; 55(4):1445-1451. PubMed ID: 27858713 [TBL] [Abstract][Full Text] [Related]
3. Platelet Amyloid-β Protein Precursor (AβPP) Ratio and Phosphorylated Tau as Promising Indicators for Early Alzheimer's Disease. Shi Y; Gu L; Wang Q; Gao L; Zhu J; Lu X; Zhou F; Zhu D; Zhang H; Xie C; Zhang Z J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):664-670. PubMed ID: 31336382 [TBL] [Abstract][Full Text] [Related]
4. Correlation between platelet amyloid precursor protein isoform ratio and cognition in Alzheimer's disease. Liu HC; Wang HC; Ko SY; Wang PN; Chi CW; Hong CJ; Lin KN; Liu TY J Alzheimers Dis; 2007 Mar; 11(1):77-84. PubMed ID: 17361037 [TBL] [Abstract][Full Text] [Related]
5. The Distinction of Amyloid-β Protein Precursor (AβPP) Ratio in Platelet Between Alzheimer's Disease Patients and Controls: A Systematic Review and Meta-Analysis. Shi Y; Gu L; Alsharif AA; Zhang Z J Alzheimers Dis; 2017; 59(3):1037-1044. PubMed ID: 28731441 [TBL] [Abstract][Full Text] [Related]
7. Magnesium modulates amyloid-beta protein precursor trafficking and processing. Yu J; Sun M; Chen Z; Lu J; Liu Y; Zhou L; Xu X; Fan D; Chui D J Alzheimers Dis; 2010; 20(4):1091-106. PubMed ID: 20413885 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease. Liu CG; Wang JL; Li L; Wang PC Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165 [TBL] [Abstract][Full Text] [Related]
9. Platelet dysfunction in hypercholesterolemia mice, two Alzheimer's disease mouse models and in human patients with Alzheimer's disease. Plagg B; Marksteiner J; Kniewallner KM; Humpel C Biogerontology; 2015 Aug; 16(4):543-58. PubMed ID: 25947203 [TBL] [Abstract][Full Text] [Related]
10. Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice. Arbel-Ornath M; Becker M; Rabinovich-Toidman P; Gartner M; Solomon B J Alzheimers Dis; 2010; 22(2):469-82. PubMed ID: 20847413 [TBL] [Abstract][Full Text] [Related]
11. Differential level of platelet amyloid beta precursor protein isoforms: an early marker for Alzheimer disease. Di Luca M; Pastorino L; Bianchetti A; Perez J; Vignolo LA; Lenzi GL; Trabucchi M; Cattabeni F; Padovani A Arch Neurol; 1998 Sep; 55(9):1195-200. PubMed ID: 9740113 [TBL] [Abstract][Full Text] [Related]
12. ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects. Manzine PR; Marcello E; Borroni B; Kamphuis W; Hol E; Padovani A; Nascimento CC; de Godoy Bueno P; Assis Carvalho Vale F; Iost Pavarini SC; Di Luca M; Cominetti MR Biomarkers; 2015; 20(3):196-201. PubMed ID: 26220620 [TBL] [Abstract][Full Text] [Related]
13. Localization and Trafficking of Amyloid-β Protein Precursor and Secretases: Impact on Alzheimer's Disease. Agostinho P; Pliássova A; Oliveira CR; Cunha RA J Alzheimers Dis; 2015; 45(2):329-47. PubMed ID: 25589722 [TBL] [Abstract][Full Text] [Related]
14. Beta protein precursor expression in human platelets and a megakaryocyte cell line. Possible implications for the origin of cerebral amyloidosis in Alzheimer's disease. Gardella JE; Gorgone GA; Munoz PC; Ghiso J; Frangione B; Gorevic PD Lab Invest; 1992 Sep; 67(3):303-13. PubMed ID: 1405489 [TBL] [Abstract][Full Text] [Related]
15. Amyloid cascade and tau pathology cerebrospinal fluid markers in mild cognitive impairment with regards to Alzheimer's disease cerebral metabolic signature. Alexopoulos P; Guo LH; Jiang M; Bujo H; Grimmer T; Förster S; Drzezga A; Kurz A; Perneczky R J Alzheimers Dis; 2013; 36(2):401-8. PubMed ID: 23609762 [TBL] [Abstract][Full Text] [Related]
17. Plasma levels of soluble amyloid precursor protein β in symptomatic Alzheimer's disease. Alexopoulos P; Gleixner LS; Werle L; Buhl F; Thierjung N; Giourou E; Kagerbauer SM; Gourzis P; Kübler H; Grimmer T; Yakushev I; Martin J; Kurz A; Perneczky R Eur Arch Psychiatry Clin Neurosci; 2018 Aug; 268(5):519-524. PubMed ID: 28602012 [TBL] [Abstract][Full Text] [Related]
18. A new sandwich immunoassay for detection of the α-secretase cleaved, soluble amyloid-β protein precursor in cerebrospinal fluid and serum. Taverna M; Straub T; Hampel H; Rujescu D; Lichtenthaler SF J Alzheimers Dis; 2013; 37(4):667-78. PubMed ID: 23948916 [TBL] [Abstract][Full Text] [Related]
19. Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease. Zainaghi IA; Talib LL; Diniz BS; Gattaz WF; Forlenza OV J Neural Transm (Vienna); 2012 Jul; 119(7):815-9. PubMed ID: 22573143 [TBL] [Abstract][Full Text] [Related]
20. Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms. Borroni B; Colciaghi F; Corsini P; Akkawi N; Rozzini L; Del Zotto E; Talarico G; Cattabeni F; Lenzi GL; Di Luca M; Padovani A Neurol Sci; 2002 Dec; 23(5):207-10. PubMed ID: 12522675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]